Principal Financial Group
YARW

Principal Financial Group’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Principal Financial Group’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$14K – 2653
2021
Q3 		$14K Sell
11
-2
-15% -$3.88K ﹤0.01% 2573
2021
Q2 		$42K Buy
+13
New +$51.5K ﹤0.01% 2582
2020
Q4 		– Sell
-3
Closed -$19K – 2462
2020
Q3 		$19K Buy
+3
New +$17.5K ﹤0.01% 2315

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Principal Financial Group's YARW Position: Q4 2021 in Review

Principal Financial Group sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2021, closing a stake of 11 shares — an estimated $14K sold.

Principal Financial Group first reported a position in YARW in Q3 2020 and held it in 3 quarters. The position peaked at $42K in Q2 2021. 49 funds tracked by Wall St. Rank hold YARW as of Q4 2021.

  • Principal Financial Group reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 11 Yarrow Bioscience, Inc. Common Stock shares in Q4 2021, an estimated $14K.
  • Principal Financial Group first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Principal Financial Group's Yarrow Bioscience, Inc. Common Stock position peaked at $42K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.